Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Performs first human implants in two patients of its Kinetra neurostimulator as part of a three-month safety and performance study, the firm says Aug 13. The study aims to support CE mark approval of the device and will involve 15-20 centers in Europe, Canada, and Australia. The Kinetra connects to two leads in the brain, eliminating the need to implant two separate neurostimulators in essential tremor or Parkinson's disease patients with bilateral symptoms, Medtronic claims
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.